Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
Articles published in the journal may be accompanied by lay-level summaries, to assist patients, caregivers and others in understanding important medical advances.
Letter to the Editor
Authors’ Reply to Schoenfeld: “Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors”
- Journal Title
- Volume 1 / 1971 - Volume 77 / 2017
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.